Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons.

Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I; HNRC Group.

J Int Neuropsychol Soc. 2004 Jan;10(1):1-14.

PMID:
14751002
2.

Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection.

Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, Grant I.

AIDS Behav. 2006 Mar;10(2):185-90.

PMID:
16477511
3.

Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine.

Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, Gragg B, Grant I; HIV Neurobehavioral Research Center Group.

Neurology. 2005 Apr 26;64(8):1343-7.

PMID:
15851720
4.

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease.

Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, Heaton RK, McCutchan JA, Grant I; HNRC Group.

AIDS. 2005 Oct;19 Suppl 3:S72-8.

PMID:
16251831
5.

Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users.

Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton R, Ellis R, Masliah E; HNRC Group.

Neurology. 2006 Oct 24;67(8):1486-9.

PMID:
17060582
6.

Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure.

Chang L, Smith LM, LoPresti C, Yonekura ML, Kuo J, Walot I, Ernst T.

Psychiatry Res. 2004 Dec 15;132(2):95-106.

PMID:
15598544
7.

Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.

Cherner M, Ellis RJ, Lazzaretto D, Young C, Mindt MR, Atkinson JH, Grant I, Heaton RK; HIV Neurobehavioral Research Center Group.

AIDS. 2004 Jan 1;18 Suppl 1:S27-34.

PMID:
15075495
8.

The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence.

Sadek JR, Vigil O, Grant I, Heaton RK; HNRC Group.

J Clin Exp Neuropsychol. 2007 Apr;29(3):266-76.

PMID:
17454347
9.

Cognitive risk factors and neuropsychological performance in HIV infection.

Claypoole KH, Townes BD, Collier AC, Marra C, Longstreth WT Jr, Cohen W, Martin D, Coombs RW, Goldstein D, Sanchez P, et al.

Int J Neurosci. 1993 May;70(1-2):13-27.

PMID:
8083020
10.

The relationship between employment and neuropsychological impairment in HIV infection.

van Gorp WG, Baerwald JP, Ferrando SJ, McElhiney MC, Rabkin JG.

J Int Neuropsychol Soc. 1999 Sep;5(6):534-9.

PMID:
10561934
11.

Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS.

Pereda M, Ayuso-Mateos JL, Gómez Del Barrio A, Echevarria S, Farinas MC, García Palomo D, González Macias J, Vázquez-Barquero JL.

Psychol Med. 2000 Jan;30(1):205-17.

PMID:
10722191
12.

The impact of HIV-associated neuropsychological impairment on everyday functioning.

Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I; HNRC Group.

J Int Neuropsychol Soc. 2004 May;10(3):317-31.

PMID:
15147590
13.

The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group.

Marcotte TD, Heaton RK, Wolfson T, Taylor MJ, Alhassoon O, Arfaa K, Ellis RJ, Grant I.

J Int Neuropsychol Soc. 1999 Nov;5(7):579-92. Erratum in: J Int Neuropsychol Soc 2000 Nov;6(7):854.

PMID:
10645701
14.

Patterns of selective neuronal damage in methamphetamine-user AIDS patients.

Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E; HIV Neurobehavioral Research Center Group.

J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):467-74.

PMID:
14657756
15.

[Study of HIV-related neuropsychological impairment: a review of methodological aspects].

RodríIguez Alvarez M, Rodriguez Salgado D.

Actas Esp Psiquiatr. 2003 Mar-Apr;31(2):79-84. Review. Spanish.

PMID:
12677472
16.

Neuropsychological performance in HIV-1-infected drug abusers.

Grassi MP, Perin C, Clerici F, Zocchetti C, Cargnel A, Mangoni A.

Acta Neurol Scand. 1993 Aug;88(2):119-22.

PMID:
8213055
17.

Neuropsychological evaluation of neurologically asymptomatic HIV-infected children.

Bisiacchi PS, Suppiej A, Laverda A.

Brain Cogn. 2000 Jun-Aug;43(1-3):49-52.

PMID:
10857661
18.
19.

Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals.

Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway GP, Flynn NM, Henik A, Pfefferbaum A, Sullivan EV.

Psychiatry Res. 2002 Aug 5;111(1):65-74.

PMID:
12140121
20.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451

Supplemental Content

Support Center